Akeso Inc. Logo

Akeso Inc. (AKESF)

OTC

Currency in USD
11.50
0.00 (0.00%)

Closed

Aug 21, 2026

Day's Range

11.50
11.50

52 wk Range

10.50
23.15

Overview - AKESF - Akeso Inc.

Key Statistics

Valuation

Enterprise Value

873.64M

P/E (Trailing)

‪25.67‬

Price / Sales (TTM)

‪3.46‬

Price / Book

‪7.87‬

EV / EBITDA

‪-7.80‬

Profitability

Profit Margin

‪-36.41%‬

Operating Margin

‪-30.66%‬

Return on Assets

‪-4.32%‬

Return on Equity

‪-14.53%‬

Ownership

Shares Outstanding

921.14M

Float

721.54M

Held by Insiders

‪21.66%‬

Held by Institutions

‪32.51%‬

Price stats

Beta

‪0.02‬

50-Day Avg

‪11.91‬

200-Day Avg

‪14.28‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Shariah Compliant

Report Date: Feb 20, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - AKESF - Akeso Inc.

Peers - AKESF - Akeso Inc.

Peer Comparison

Compared with companies in Biotechnology listed on OTC.

Profile Summary - AKESF - Akeso Inc.

About

Akeso Inc. is a biotechnology company primarily dedicated to the development of innovative antibody-based therapies. Focused on cutting-edge biopharmaceutical research, Akeso Inc. plays a pivotal role in the healthcare sector, particularly within oncology and immunology. The company leverages proprietary technology…

SectorHealthcare
IndustryBiotechnology
Employees3.76K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.